CVS February Sales Increase 35.9%
Get Alerts CVS Hot Sheet
Price: $94.30 -0.47%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: +1.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: +1.8%
Join SI Premium – FREE
CVS Corporation (NYSE: CVS) announced that total sales for the four-week period ended February 26, 2005 increased 35.9% to $2.89 billion, compared to $2.13 billion in the prior year period. The increase includes the impact of the acquisition completed on July 31, 2004, of 1,268 Eckerd drugstores, as well as Eckerd's pharmacy benefit management and mail order pharmacy business. Total pharmacy sales represented 70.2% of total company sales in February.
Same store sales for the four weeks ended February 26, 2005 increased 9.2% over the comparable prior year four-week period. Pharmacy same store sales increased 10.5%, while front-end same store sales increased 6.4%. Same store sales do not include the acquired Eckerd drugstores, which will be included in same store sales beginning in August 2005.
Same store sales for the four weeks ended February 26, 2005 increased 9.2% over the comparable prior year four-week period. Pharmacy same store sales increased 10.5%, while front-end same store sales increased 6.4%. Same store sales do not include the acquired Eckerd drugstores, which will be included in same store sales beginning in August 2005.
You May Also Be Interested In
- MinuteClinic® opens three new retail medical clinics to serve Massachusetts patients
- CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
- Raymond James: 'We expect AT&T to focus spectrum acquisitions on fiberheavy areas going forward to support that converged effort.'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share